Patents by Inventor James S. Rowe

James S. Rowe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITIONS FOR SUSTAINED DELIVERY OF BENZODIAZEPINE ANTAGONISTS
    Publication number: 20160120877
    Abstract: The present invention relates to sustained release formulations of benzodiazepine antagonists and their use.
    Type: Application
    Filed: July 15, 2011
    Publication date: May 5, 2016
    Inventors: James S Rowe, Grau Consoni
  • Formulations for anaesthetic use
    Patent number: 7326735
    Abstract: A formulation for anaesthetic use is described. The formulation contains propofol, and may be used to induce and/or maintain anaesthesia or sedation in a vertebrae. The formulation additionally contains a solvent or a combination of solvents and is suitable for mixing with commonly used infusion fluids prior to injection in to a patient. The formulation may be terminally sterilised using moist heat in order to assure sterility, and contains no lipid, thereby avoiding complications associated with administration over prolonged periods of time, or to patients with disorders of fat metabolism.
    Type: Grant
    Filed: April 28, 2004
    Date of Patent: February 5, 2008
    Assignee: Parnell Laboratories (Aust) Pty Limited
    Inventors: Alan R. Bell, Fenella Cochrane, Geoffrey N. O'Connor, James S. Rowe
  • Encapsulation of indomethacin
    Patent number: 4442051
    Abstract: Indomethacin is encapsulated by aqueous gelatin/polysaccharide coacervation by first forming a dispersion or paste of Indomethacin in a water-miscible liquid polyhydroxyalkane. Preferably the coacervate system is gelatin/acacia and the polyhydroxyalkane is glycerol.
    Type: Grant
    Filed: December 11, 1981
    Date of Patent: April 10, 1984
    Assignee: Nicholas Proprietary Limited
    Inventors: James S. Rowe, John E. Carless